Oliver Tracie
SEC CIK 1935706 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Chief Commercial Off | 127.1K | — | $555.1K | 5 | 2023-01-04 | 2024-07-02 |
Most active insiders at ARWR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anzalone Christopher Richard | CEO, Dir | — | $24.01M |
| 2 | Hamilton James C | Chief Medical Off | — | $4.63M |
| 3 | O'Brien Patrick | COO | — | $3.12M |
| 4 | PERRY MICHAEL S | Dir | — | $2.00M |
| 5 | Ferrari Mauro | Dir | — | $1.02M |
| 6 | Apel Daniel Joseph | CFO | — | $934.3K |
| 7 | OLUKOTUN ADEOYE Y | Dir | — | $850.5K |
| 8 | Vakiener Victoria | Dir | — | $679.5K |
| 9 | Waddill William D. | Dir | — | $566.0K |
| 10 | Lu Hongbo | Dir | — | $228.3K |
Oliver Tracie made no open-market trades at ARWR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | 2024-07-02 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Off | S - Sale | $25.28 | -9,394 | 127.1K | -7% | -$237.5K | |
| 2024-01-08 | 2024-01-04 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Off | A - Grant | $0.00 | +75.0K | 136.6K | +122% | $0 | |
| 2024-01-08 | 2024-01-05 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Off | S - Sale | $33.89 | -74 | 136.5K | -0.1% | -$2,508 | |
| 2023-07-06 | 2023-07-03 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Off | S - Sale | $35.31 | -8,925 | 61.6K | -13% | -$315.1K | |
| 2023-01-05 | 2023-01-04 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Oliver Tracie | Chief Commercial Off | A - Grant | $0.00 | +500 | 70.5K | +0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations